tiprankstipranks

Joel Mccleary Insider Profile

4 Followers
Joel Mccleary, Director at Altimmune, holds 120.17K shares in Altimmune (Ticker: ALT). Most recently, Joel Mccleary Bought $18,757 shares of Altimmune on Nov 05, 2010 for an estimated value of 47.64K.
tipranks
Joel Mccleary

Joel Mccleary
Altimmune (ALT)
Director

Not Ranked
Joel Mccleary has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$886K
100.00%
A breakdown of Joel Mccleary's holdings

Insider Roles

Altimmune
(ALT)
Director
Roles that Joel Mccleary holds in companies

Most Profitable Insider Trade

Stock:
Altimmune
(ALT)
Rating:Informative Buy
Date:Nov 05, 2010 - Nov 05, 2011
Return:-52.00%
The most profitable trade made by Joel Mccleary

Joel Mccleary's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Altimmune
Nov 05, 2010
Director
Informative Buy
47.64K
$885.63K
Success Rate for
ALT
0 out of 1 profitable transactions on
ALT
0%
Average Return for
ALT
Average return per transaction on
ALT
-52.00%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Nov 05, 2010
Informative Buy
$47.64K
-
$2.54
-52.00%
List of latest transactions for each holding click on a transaction to see Joel Mccleary's performance on stock

Joel Mccleary insider profile FAQ

What is the percentage of profitable transactions made by Joel Mccleary?
The percentage of profitable transactions made by Joel Mccleary is ―.
    What is the average return per transaction made by Joel Mccleary?
    The average return per transaction made by Joel Mccleary is ―.
      What stocks does Joel Mccleary hold?
      Joel Mccleary holds: ALT stocks.
        What was Joel Mccleary’s latest transaction?
        Joel Mccleary latest transaction was an Informative Buy of $47.64K.
          What was Joel Mccleary's most profitable transaction?
          Joel Mccleary’s most profitable transaction was an Informative Buy of ALT stock on November 5, 2010. The return on the trade was -52.00%.
            What is Joel Mccleary's role in Altimmune?
            Joel Mccleary's role in Altimmune is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.